The 13th edition of the TOP 100 Swiss Startup Award celebrated Switzerland’s best startups according to a 100-person strong jury with HAYA Therapeutics top winner on the podium
Organized by Venturelab, the TOP 100 Swiss Startup Ranking showcases the 100 Swiss startups with the greatest potential according to a jury of 100 investors and experts from all over Switzerland. The list is completed by start-ups selected by public voting in several fields of interest like Medtech, Biotech, Cleantech and more.
Biopôle’s members ranking includes:
1st place: HAYA Therapeutics
The biotech startup HAYA Therapeutics develops precision drugs. The lead candidate for cardiac fibrosis – a condition for which almost no effective treatment exists apart from a heart transplant – is currently in the preclinical phase. The basis for drug development is a platform that finds targets in the previously unexploited portion of the human genome and serves to develop matching drugs. HAYA has 33 employees and offices at Biopôle in Epalinges close to Lausanne and in San Diego. The company raised about USD25 million in its seed round. It was founded in 2019 by Samir Ounzain and Daniel Blessing and ranked 8th in 2022.
8th place: Resistell | 1st Medtech ranking
11th place: Volumina | 2nd Medtech ranking
55th place: SEED Biosciences | 7th Biotech ranking
92th place: Limula | Biotech public voting winner
+ Voltiris Cleantech public voting winner
